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Abstract 
Continuous monitoring of oxygenation with pulse oximetry is the standard of care for critically ill neonates. A better 
understanding of its measurement bias compared to arterial oxygen saturation could be helpful both for the clinician 
and researcher. Towards that end, we examined the electronic database from a large neonatal ICU. From a 24-month 
period we identified 25,032 paired SpO2-SaO2 measurements from 1,007 infants who were receiving supplemental 
oxygen during mechanical ventilation. We found that SpO2 was consistently higher than SaO2. The size of the bias was 
fairly constant when SpO2 was between 75–93%, above which it dropped steadily. The median size of this bias was 1% 
SpO2 during hyperoxemia (SpO2 97–100%) with a median variation of 1.3% above and below. During periods of 
hypoxemia (SpO2 75–85%) and normoxemia (SpO2 89–93%) the bias was approximately 5% SpO2, with a median 
variation of 5% above and below. 
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Background 
Use of the noninvasive pulse oximeter (SpO2) in 
medicine is ubiquitous. Continuous monitoring of SpO2 
to manage oxygenation is the standard of care in 
neonatal critical care. [1, 2] These continuous readings 
are complemented with periodic arterial blood gas 
analysis, as well as transcutaneous O2-CO2 measure-
ments, and more recently near infrared tissue oxygen 
assessment. Nevertheless continuous SpO2 is the pri-
mary measure used to manage oxygenation in the 
neonatal intensive care unit (NICU). 
The reliability of pulse oximetry has improved since 
it was introduced into the NICU 30 years ago. The 
accuracy of newer generation devices introduced more 
than a decade ago has been studied showing reasonable 
agreement with arterial blood near desirable levels, but 
marked bias outside. [3, 4] A better understanding of 
the limitations could perhaps enhance clinical decision-
making and also help those who are modeling and 
developing  oxygenation control systems. 
We accessed a large clinical database with the goal 
of providing more detailed current information on the 
bias between calculated arterial saturation (SaO2) and 
SpO2 as measured with leading oximetry technology. 
Methods 
The data is from the 58-bed NICU at Children’s 
Hospital Los Angeles. [5] It is a University affiliated 
tertiary care center in the United States. The Investiga-
tional Review Board has waived the need for informed 
consent for aggregate data analysis studies and specifi-
cally approved this project. 
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The oximeter in the patient monitoring system uses 
Masimo SET technology (Masimo Corporation, Irvine, 
California). Infants were included in this analysis if 
they were receiving support from a mechanical 
ventilator and supplemental oxygen at the time of the 
measurement. All complete arterial blood gas analyses 
that included pH, PaCO2, PaO2, SaO2 and FiO2 were 
identified. SpO2 values less than 75% were excluded. 
The SaO2 was calculated using standard algorithms 
incorporated into the blood gas system (epoc®, Alere, 
Watham Massachusetts). These records were linked to 
another file with 30-second SpO2 readings (10-second 
averaging) from the patient monitor. The SpO2 value 
used in the analysis was the mean of 4 SpO2 readings in 
the minute before and after the arterial blood 
collection. 
The intent to group saturation risk categories was 
prospective. However the three SpO2 risk groups were 
selected after reviewing the initial bias data, to insure 
within group results had consistent bias, if possible. 
The categories selected were high risk of hypoxemia 
(75–85% SpO2), likely normoxemia (89–93% SpO2) 
and high risk of hyperoxemia (97–100% SpO2). 
The purpose of this analysis was not to assess the 
accuracy of SpO2, but rather to identify the expected 
difference between a SpO2 level and a simultaneous 
calculated arterial SaO2. For that reason we chose not 
to apply the Bland-Altman convention of using the 
average of SpO2 and SaO2 as the independent variable 
or a scatter plot with 95% confidence limits. Rather we 
selected metrics to describe the actual size and 
variability of the difference between these two 
measures. Bias size was defined by the mean and 
median of the difference between SpO2 and SaO2. Bias 
variability was defined as the median of the absolute 
value of the differences between the bias size for each 
respective SpO2 risk category. 
We determined that with a sample size of 100 per 
category we would be able to detect the difference in 
bias of 1±2 STD with a power >0.8 and a threshold for 
significance of p<0.05. We chose to use available data 
from a 24-month period previously collected to insure 
an adequate sample per category. 
Differences between medians were evaluated using 
Kruskal-Wallis or Mann-Whitney U tests. Statistical 
tests were conducted with XLSTAT v19.02 (Addinsoft, 
Paris, France). A two-tailed p<0.05 was considered 
statistically significant. 
Results 
We evaluated 25,032 SpO2-SaO2 measurements from 
1,007 infants. Their median age was 13 days (IQR: 3–
34). The median number of SpO2-SaO2 pairs/SpO2-bin 
was 462 (IQR: 384–1006). 
Details of the gas exchange of these infants are 
shown in Table 1. The median values of these para-
meters are all consistent with nominally accepted target 
values for critically ill neonates. Nevertheless more 
than 50% of the SaO2 values were either hypoxemic or 
hyperoxemic. In addition, other values outside the 
bounds of the IQR reflect a wide range well beyond 
normal. The median difference between the SaO2 and 
SpO2 was 2 (IQR 0–6, P<0.001). 
Figure 1 shows the bias across the range of indi-
vidual SpO2 bins. It includes the mean with its 95% 
confidence limits, as well as the median. The median 
bias is consistently lower than the mean bias and 
generally outside the confidence limits of the mean, 
confirming marked skew. Whether considering the 
median or mean, the magnitude of the bias is clearly 
not constant across the range.  Between 75–93%, SpO2 
reads markedly higher than SaO2. In contrast, between 
94–100% the difference between SpO2 and SaO2 is not 
only much smaller but also tends to drop with 
increasing SpO2. 
 
Table 1: Gas Exchange Parameters. 
 
Median IQR 
SaO2 (%) 94 83–98 
SpO2 (%) 97 90–100 
SpO2 -SaO2 2 0–6  
PaCO2 mmHg 45 40–52 
pH 7.380 7.330–7.430 
PaO2 mmHg 74 50–110 
FiO2 (%) 45  35–67 
PaO2 /FiO2 168 100–260 
 
Table 2: Size & Variability of Bias by Oxemia Category. 
Oxemia 
category n 
Size      
Median  
(IQR) 
Variability 
Median  
(IQR) 
Hypoxemic  
(SpO2 75–85%) 
 
4,533 
 
5 
(1–11) 
5.1  
(2.1–8.9)* 
Normoxemic 
(SpO2 89–93%) 
 
3,034 
 
6 
(1–11) 
4.8  
(2.2–8.2)* 
Hyperoxemic 
(SpO2 97–100%) 
 
12,585 
 
1 
(0–3) 
1.3  
(0.8–2.8)* 
* P<0.001 between all categories 
 
The size and variability of the bias for the three 
categories of SpO2 risk are shown in Table 2. The 
differences in the median size are predictable, 5, 6 and 
1, consistent with the figure. The later (hyperoxemia) 
was statistically significantly smaller (P<0.001). The 
median variability in the three SpO2 risk ranges is 
relatively large. As a percent of the bias they are 
hypoxemia (102%), normoxemia (80%) and 
hyperoxemia (130%). The differences in variability are 
ORIGINAL RESEARCH  
132 
 
Lekar a technika – Clinician and Technology 2017, vol. 47(4), pp. 130–134 
ISSN 0301-5491 (Print), ISSN 2336-5552 (Online) 
statistically different (P<0.001). The lower bound of 
the IQRs is near zero, and 16% of the biases are 
negative. 
Discussion 
We believe this is the first large study of SpO2-SaO2 
bias in critically ill neonates using the current 
generation of SpO2 technology. We found that SpO2 
was consistently higher than the calculated SaO2. In 
SpO2 values associated with neonatal hypoxemia and 
normoxemia, we found that the average size of bias 
from SaO2 was marked but consistent. In contrast at 
levels of SpO2 associated with hyperoxemia, the 
average level of bias was much smaller. 
In 2014 Ross et al compared SpO2 and SaO2 in 212 
infants and children in 5 pediatric ICUs. [3] They 
analyzed 1,980 SpO2-SaO2 measurements. The SpO2 
measurements used different pulse oximeters, and SaO2 
was measured directly with co-oximetry. Consistent 
with our finding they reported smaller bias at higher 
levels of SpO2. They further reported that the bias was 
larger between 81–85%. This is not particularly evident 
in our data. The size of these biases was also slightly 
smaller than we reported. These small differences  
 
 
could be a result of the lack of accuracy of the calcu-
lated SaO2 as compared to its direct measurement with 
co-oximetery. Ross also reported significant bias 
effects associated with infants with cardiovascular 
anomalies and the miss-use of the oximeter sensor. 
They did not identify any significant differences 
between oximeters or infants and children. These 
former two might also have contributed to the 
differences in results. 
Rosychuk et al reported on a comparison of 1,032 
paired SpO2-SaO2 measurements with SpO2 levels 
between 85–95%. [4] These were very preterm 
neonates in the first week of life, who had not received 
a transfusion, and thus have a high level of fetal 
hemoblobin. The SpO2 measurements were made with 
Massimo SET technology. They reported, in contrast to 
our findings and those of Ross, that the bias was 
similar above and below a SpO2 of 90%. However, 
there were only 101 values between 85–89%, limiting 
this finding. They also reported a much smaller bias, 
for SpO2 levels 91–95%. Some of this difference 
among studies could be related to the higher fetal 
hemoglobin [6, 7] in these infants, than in other 
studies. Like Ross they also measured SaO2 with co-
oximetry, limiting the possibility of this difference 
being relating to errors between measured and 
calculated SaO2. 
 
 
Figure 1: Bias Size median, mean and 95% CL SEM. Median is depicted as a circle and mean as a diamond. The grey 
bar is the 95% confidence limits of the standard  error of the mean. 
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As noted above, consistent with the finding of Ross, 
our data reflect markedly difference levels of bias 
between low and high SpO2 readings. This suggests 
may be kinked at 94% SpO2. Johnston et al, described 
a discontinuity in the internal calibration curve of the 
Massimo SET oximeter technology. [8] They ob-
served that this resulted in a dip in the histogram of 
SpO2 between 87–90%. They further confirmed that 
updated software made available in 2011 to address 
this issue resulted in little apparent bias with other 
oximeters. Our data reflects a bias that is very 
consistent between 87–90% SpO2, supporting that the 
error reported by Johnson was indeed not present. 
However it suggests the possibility that a similar 
distortion could now be present between 93–96% 
SpO2, if the transition between the two sections of the 
calibration curves was not smooth. Our bias levels at 
SpO2 values of 75%, 86% and 100% also suggest 
potential discontinuities. We can not rule out that 
these effects are related to the use of calculated SaO2. 
However the calculation equation is a continuous 
function, not subject to discontinuities but still pos-
sibly skewed. 
We found the variability of the bias was quite large. 
This finding is consistent with the reports of Ross and 
Rosychuk. However, the metrics of variability differ 
among the studies so exact comparisons are difficult. 
Rosychuk reported that the span of the 95% limits of 
uncertainty was higher for SpO2 values between 85–
89% than those between 91–95% (18.2%, and 10.4% 
SpO2 respectively). This difference is most possibility 
a result of the limited number of samples in the lower 
range. Ross reported a IQR of 5–10% in different 
SpO2 strata. These were slightly smaller than our 
comparable findings. Ross reported that the variability 
was smaller at high levels of SpO2, consistent with our 
finding and those of Rosychuk. 
Gerstmann et al, conducted a study similar to ours 
based on a database from the 1991–1997. [9] Their 
evaluation of this earlier oximeter technology found 
“optimal” agreement in a narrow clinical band, and 
significant bias outside 92–97% SaO2. They also 
reported an increase in bias with decreasing SaO2, and 
SpO2 values smaller than SaO2 above 95%. Neither of 
these is consistent with our results or those of Ross or 
Rosyshuk. It is reasonable to assume the differences 
are a reflection of the newer oximeter technology. 
Our study has some limitations. First the SpO2 data 
is an average of the two minutes coincident with the 
arterial blood gas, and no effort was made to eliminate 
comparisons where the SpO2 or the infant were 
unstable at that time, as others have done. Doing so 
would have reduced the variability, but probably not 
the size of the bias. Thus our findings reflect real 
clinical situations and not idealized laboratory 
comparisons. Second the SaO2 values that we reported 
were calculated by the blood gas analyzer, not directly 
measured by a co-oximeter. These calculations take 
into account pH and PaCO2 but not other factors 
affecting the SaO2-PaO2 relationship. [10] Direct 
measurement of SaO2 with a co-oximeter is rarely 
used today in the NICU. It is comforting that our 
results were consistent with those reported by Ross 
using a co-oximeter. Finally a single average of 4 
values of SpO2 over 2 minutes is seldom used in the 
NICU, rather staff are well versed at integrating 
problems from motion artifact and poor perfusion 
when accessing the trend, mitigating the impact of the 
point variability we reported. 
Conclusions 
We found that SpO2 readings are usually higher 
than calculated SaO2 across the entire clinical range. 
The size of the bias is quite similar in SpO2 ranges 
associated with hypoxemia and normoxemia, but is 
decreased significantly in higher ranges associated 
with hyperoxemia. We hope this data will provide 
additional insight to clinicians as they assess neonatal 
oxygenation based on continuous non-invasive pulse 
oximetery. We also expect this information should be 
helpful to those designing neonatal oxygen control 
systems and modeling neonatal oxygenation. 
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